BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 20650546)

  • 21. Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infection due to Staphylococcus aureus.
    Wisplinghoff H; Seifert H; Coimbra M; Wenzel RP; Edmond MB
    Clin Infect Dis; 2001 Sep; 33(5):733-6. PubMed ID: 11486296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome.
    Du B; Long Y; Liu H; Chen D; Liu D; Xu Y; Xie X
    Intensive Care Med; 2002 Dec; 28(12):1718-23. PubMed ID: 12447513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiological comparison of true methicillin-resistant and methicillin-susceptible coagulase-negative staphylococcal bacteremia at hospital admission.
    Tacconelli E; D'Agata EM; Karchmer AW
    Clin Infect Dis; 2003 Sep; 37(5):644-9. PubMed ID: 12942394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology of pediatric community-acquired bloodstream infections in a children hospital in Paris, France, 2001 to 2008.
    Doit C; Mariani-Kurkdjian P; Mahjoub-Messai F; Bidet P; Bonacorsi S; Carol A; Varon E; Bingen E
    Diagn Microbiol Infect Dis; 2010 Mar; 66(3):332-5. PubMed ID: 20159378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Changes in patterns and resistances of bacteria from 731 patients with bacteremia in 11 years].
    Xin J; Xiang Y; Zhang J
    Zhonghua Yi Xue Za Zhi; 1997 May; 77(5):332-5. PubMed ID: 9772485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis.
    Rodríguez-Baño J; Picón E; Gijón P; Hernández JR; Ruíz M; Peña C; Almela M; Almirante B; Grill F; Colomina J; Giménez M; Oliver A; Horcajada JP; Navarro G; Coloma A; Pascual A;
    Clin Infect Dis; 2010 Jan; 50(1):40-8. PubMed ID: 19995215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study.
    Chang FY; Peacock JE; Musher DM; Triplett P; MacDonald BB; Mylotte JM; O'Donnell A; Wagener MM; Yu VL
    Medicine (Baltimore); 2003 Sep; 82(5):333-9. PubMed ID: 14530782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nasal carriage of meticillin resistant Staphylococcus aureus: the prevalence, patients at risk and the effect of elimination on outcomes among outclinic haemodialysis patients.
    Lederer SR; Riedelsdorf G; Schiffl H
    Eur J Med Res; 2007 Jul; 12(7):284-8. PubMed ID: 17933699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections.
    Kopp BJ; Nix DE; Armstrong EP
    Ann Pharmacother; 2004 Sep; 38(9):1377-82. PubMed ID: 15266044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy.
    Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4574-81. PubMed ID: 15561828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology of community-acquired and nosocomial bloodstream infections in tropical Australia: a 12-month prospective study.
    Douglas MW; Lum G; Roy J; Fisher DA; Anstey NM; Currie BJ
    Trop Med Int Health; 2004 Jul; 9(7):795-804. PubMed ID: 15228489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Driveline infections in patients supported with a HeartMate II: incidence, aetiology and outcome.
    Bomholt T; Moser C; Sander K; Boesgaard S; Køber L; Olsen PS; Hansen PB; Mortensen SA; Gustafsson F
    Scand Cardiovasc J; 2011 Oct; 45(5):273-8. PubMed ID: 21539474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-trimoxazole versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia: a retrospective cohort study.
    Goldberg E; Paul M; Talker O; Samra Z; Raskin M; Hazzan R; Leibovici L; Bishara J
    J Antimicrob Chemother; 2010 Aug; 65(8):1779-83. PubMed ID: 20507860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome.
    Ortega M; Marco F; Soriano A; Almela M; Martínez JA; Muñoz A; Mensa J
    J Antimicrob Chemother; 2009 Mar; 63(3):568-74. PubMed ID: 19126669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia.
    Melzer M; Eykyn SJ; Gransden WR; Chinn S
    Clin Infect Dis; 2003 Dec; 37(11):1453-60. PubMed ID: 14614667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost of bacteraemia caused by methicillin-resistant vs. methicillin-susceptible Staphylococcus aureus in Spain: a retrospective cohort study.
    Rubio-Terrés C; Garau J; Grau S; Martinez-Martinez L;
    Clin Microbiol Infect; 2010 Jun; 16(6):722-8. PubMed ID: 19712112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia.
    Soriano A; Martínez JA; Mensa J; Marco F; Almela M; Moreno-Martínez A; Sánchez F; Muñoz I; Jiménez de Anta MT; Soriano E
    Clin Infect Dis; 2000 Feb; 30(2):368-73. PubMed ID: 10671343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcomes of patients receiving daptomycin for the treatment of Staphylococcus aureus infections and assessment of clinical factors for daptomycin failure: a retrospective cohort study utilizing the Cubicin Outcomes Registry and Experience.
    Sakoulas G; Brown J; Lamp KC; Friedrich LV; Lindfield KC
    Clin Ther; 2009 Sep; 31(9):1936-45. PubMed ID: 19843483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Piperacillin-resistant Escherichia coli bacteraemia: relation to empiric therapy and clinical outcome.
    Andersen NF; Møller J; Peterslund NA
    Scand J Infect Dis; 2005; 37(2):90-5. PubMed ID: 15764199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of penicillin, dicloxacillin and cefuroxime for penicillin-susceptible Staphylococcus aureus bacteraemia: a retrospective, propensity-score-adjusted case-control and cohort analysis.
    Nissen JL; Skov R; Knudsen JD; Ostergaard C; Schønheyder HC; Frimodt-Møller N; Benfield T
    J Antimicrob Chemother; 2013 Aug; 68(8):1894-900. PubMed ID: 23599360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.